161822-04-4 Usage
Description
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide is a complex organic molecule that contains amino groups and hydroxyl groups. It is composed of cyclohexyl, butanamide, and various amino sugar moieties. (2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide is likely to have biological activity and may be involved in biological processes such as protein synthesis or cell signaling. Its detailed structure suggests that it may have a role in the formation or modification of glycoproteins or glycolipids. Further research is needed to understand its specific biological function and potential applications.
Uses
Used in Pharmaceutical Industry:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide is used as a potential pharmaceutical candidate for the development of new drugs due to its complex structure and the presence of various functional groups that may interact with biological targets.
Used in Biochemical Research:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-( aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide is used in biochemical research to study the role of amino sugar moieties in the formation and modification of glycoproteins and glycolipids. Understanding its interactions with these biomolecules can provide insights into the underlying mechanisms of various biological processes.
Used in Drug Delivery Systems:
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-3,5-diamino-4-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-[(2S,3R,4R,5S,6R)-3,4-diamino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-cyclohexyl]-2-hydroxy-butanamide can be used in the development of drug delivery systems, where its complex structure and functional groups can be utilized to improve the delivery and efficacy of therapeutic agents.
Note: The provided materials do not specify any particular applications for this compound. The suggested uses are based on the general properties and potential of complex organic molecules with similar structures. Further research and development are required to validate these applications.
Check Digit Verification of cas no
The CAS Registry Mumber 161822-04-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,1,8,2 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 161822-04:
(8*1)+(7*6)+(6*1)+(5*8)+(4*2)+(3*2)+(2*0)+(1*4)=114
114 % 10 = 4
So 161822-04-4 is a valid CAS Registry Number.
InChI:InChI=1/C22H46N8O8/c23-4-3-12(32)20(34)30-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)16(29)19(11)38-22-15(28)14(27)17(33)13(7-31)36-22/h8-19,21-22,31-33H,1-7,23-29H2,(H,30,34)/t8-,9+,10-,11+,12-,13+,14+,15+,16+,17+,18+,19-,21+,22+/m0/s1
161822-04-4Relevant articles and documents
Synthesis of 2'-amino-2'-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus
Kondo,Ikeda,Ikeda,Takeuchi,Usui,Ishii,Kudo,Gomi,Shibahara
, p. 821 - 832 (2007/10/02)
Based on our studies on the enzymatic modifications of arbekacin by methicillin-resistant Staphylococcus aureus (MRSA), replacement of the 2'-hydroxyl group by an amino group in arbekacin was designed to synthesize derivatives that would be active against
